Digest Archive

Newsletters in our archives exploring the latest trends in synthetic biology.
June 17, 2020
Current Issue
#339 COVID-19 antibodies for everyone! + GreenLight raises $102M, Verve $63M, and Bit Bio $41.5M
June 11, 2020
#338 👋My talk with California’s Lt. Governor, LanzaJet, $700m+ in new funding
Reach Your
Advertise in the SynBioBeta Digest
June 3, 2020
#337 👉Today from 8 am PDT, choose from 33 breakouts! @ Built with Biology + a $4 trillion gold rush and living bacteria as cancer drugs
May 28, 2020
#336 A Bioeconomy Bonanza: Insitro raises $143M, AbCellera $105M, Ginkgo $70M, and Benchling $50M
May 22, 2020
#335 Octant raises $30M for drug discovery, U.S. Senate’s bioeconomy bill, and mice 🐭
May 13, 2020
#334 ▶️ SynBioBeta Vaccine Report Friday at 8am PDT. Plus: Jolting pharma out its rut and trying alternative meat
May 8, 2020
#333 ▶️ SynBioBeta Vaccine Report May 15, Eric Schmidt’s advice for synthetic biology, Pivot’s $100m + GRAIL’s $390m!
April 29, 2020
#332 Global antibody defense Monday at 8am, #BuiltWithBiology Summit May 13 🧬
April 23, 2020
#331 Tomorrow @8am, COVID-19 diagnostics, + EnginZyme’s €6.4m Series A.
April 21, 2020
#330 Tomorrow @ 8am on SynBioBeta Live: Pam Silver, Esther Dyson, Drew Endy, Steve Kwast, Karen Watson & Nishan Degnarain - We’re not going back to normal.

Who We Are.

We are a team of creative minds that are committed to help build the future with biology. We believe synthetic biology is the answer to many issues we are facing today and want to help tell that story to the world. We bring together the leader in the industry and connect them to each other and the rest of the world. Join our journey.